Centre for Cancer Biology and Department of Haematology, SA Pathology, Adelaide, Australia.
Leuk Res. 2012 Jan;36(1):110-6. doi: 10.1016/j.leukres.2011.09.013. Epub 2011 Oct 11.
Krüppel-like factor 5 (KLF5) has been implicated as a tumor suppressor in various solid tumors such as breast and prostate, and recent studies have demonstrated a role for this protein in neutrophil differentiation of acute promyelocytic leukemia cells in response to ATRA. Here, we show that KLF5 expression increases during primary granulocyte differentiation and that expression of KLF5 is a requirement for granulocyte differentiation of 32D cells. In AML, we show that KLF5 mRNA expression levels are reduced in multiple French-American-British subtypes compared to normal controls, and also in leukemic stem cells relative to normal hematopoietic stem cells. We demonstrate that in selected AML cases, reduced expression is associated with hypermethylation of the KLF5 locus in the proximal promoter and/or intron 1, suggesting that this may represent a Class II genetic lesion in the development of AML.
Krüppel 样因子 5(KLF5)已被认为是多种实体瘤(如乳腺癌和前列腺癌)中的肿瘤抑制因子,最近的研究表明,该蛋白在 ATRA 诱导的急性早幼粒细胞白血病细胞中性粒细胞分化中发挥作用。在这里,我们表明 KLF5 的表达在原粒细胞分化过程中增加,并且 KLF5 的表达是 32D 细胞粒细胞分化的必需条件。在 AML 中,我们表明与正常对照相比,多种 French-American-British 亚型的 KLF5 mRNA 表达水平降低,与正常造血干细胞相比,白血病干细胞中 KLF5 的表达水平也降低。我们证明,在某些 AML 病例中,表达降低与近端启动子和/或内含子 1 中 KLF5 基因座的高甲基化有关,提示这可能代表 AML 发展中的 II 类遗传损伤。